Epilepsy trials in Sweden
3 of 9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleModified Ketogenic Diet on Drug-Resistant Epilepsy in Adults - a Prospective Observational Study of Real-world Data
- Where
- Stockholm
- Age
- 18 years and over
- People
- 150
- Run by
- Karolinska Institutet
See details and how to joinNCT07878104 - Phase 3Not yet taking people in SwedenCOMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"
- Where
- Stockholm
- Age
- 2 years and over
- People
- 438 worldwide
- Run by
- Yale University
See details and how to joinNCT07281027 - Phase 1Taking peopleA randomized, multiple ascending doses, clinical trial to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of CV-01 after double-blind, placebo-controlled multiple oral administrations for 2 weeks in healthy volunteers, and multiple oral administrations open-label for 2 weeks in a cohort of participants with drug resistant epilepsy
- Where
- Moelndal, Uppsala
- Age
- 18 years and over
- People
- 36
- Run by
- Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Enunciabile Anche Angelini Pharma Italia S.p.A. Angelini Pharma S.p.A. A.C.R.A.F. S.p.A. Acraf S.p.A. Angelini S.p.A. aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.
See details and how to join2026-525478-21-00